Lundbeck's new drug application (NDA) for Vyepti® (eptinezumab) accepted by Japan's Ministry of Health, Labor and Welfare (MHLW), marking a significant step forward towards expanding access to the ...
TOKYO and CAMBRIDGE, Mass., Jun 8, 2023 - (JCN Newswire) - - Eisai Co., Ltd. and Biogen Inc. (Nasdaq: BIIB) announced today that Eisai has submitted a marketing authorization application for lecanemab ...
Drugmaker Wockhardt said it has successfully filed a Marketing Authorisation Application (MAA) with the European Medicines Agency (EMA) for its novel antibiotic, WCK 5222. The EMA reviews scientific ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results